• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    China Everbright (SEHK:165) Moved Higher, What Is Drawing Attention Now?

    Simply Wall St·09/21/2026 10:21:45
    Listen to the news

    China Everbright (SEHK:165) has been dropped from the FTSE All-World Index (USD). This type of change often prompts mechanical selling as index-tracking funds and benchmarked investors adjust positions.

    Recent trading has been choppy for China Everbright. The share price has climbed over the short term, with a 10.14% 30 day share price return and 14.50% over 90 days. However, the year to date share price return is down 33.11% and the 1 year total shareholder return has fallen 28.66%, while the 3 year total shareholder return remains positive at 46.21%. This suggests that recent momentum has faded against a stronger longer term picture.

    Scan how other investors are reacting to similar pressure by reviewing the hand picked 227 resilient stocks with low risk scores that have held up better when sentiment turns against a stock like China Everbright.

    China Everbright now trades below the average analyst price target after the index exit and sharp year to date decline. Is that a genuine discount, or a fair warning label on the risks?

    Preferred Price-to-Sales Multiple of 12.9x: Is it justified?

    Valuation on China Everbright today hinges on a steep price tag. The shares last closed at HK$6.36, while trading on a P/S ratio of 12.9x that is materially richer than both peers and the broader Hong Kong capital markets group.

    The P/S ratio compares the company’s market value to its revenue. For a financial services group like China Everbright, which is currently unprofitable but has meaningful fee and investment income, investors often focus on this measure when earnings are volatile or negative.

    Here that benchmark runs hot. The P/S of 12.9x is almost double the peer average of 6.7x, and it is far above the Hong Kong Capital Markets industry average of 2.8x. Based on the estimated fair P/S ratio of 1.2x, the current level implies a very strong premium. The market could reassess this if expectations around the business shift.

    Explore the SWS fair ratio for China Everbright.

    Result: Price-to-Sales ratio of 12.9x (OVERVALUED)

    Still, the story around China Everbright can change quickly if fee income weakens or if prolonged losses limit the amount of capital the business can commit to new investments.

    Find out about the key risks to this China Everbright narrative.

    Next Steps

    Mixed signals around China Everbright can feel confusing. Move quickly and weigh the full picture yourself by checking the 1 key reward and 1 important warning sign.

    Looking for more investment ideas beyond China Everbright?

    If China Everbright has you rethinking concentration risk, you may wish to broaden your opportunity set with focused lists that spotlight quality, income, and resilience before others move first.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.